Sepsis modulates aortic AT1 and P2Y6 receptors to produce vascular hyporeactivity in mice

J Recept Signal Transduct Res. 2023 Dec;43(2):37-49. doi: 10.1080/10799893.2023.2204960. Epub 2023 Apr 26.

Abstract

Purpose: Hyporeactivity to vasopressors leading to multiple organ failure is a serious clinical implication in sepsis. Though the regulatory role of purinoceptors in inflammation is reported, their involvement in sepsis-induced vasoplegia is still unknown. Thus we investigated the effect of sepsis on vascular AT1 and P2Y6 receptors.

Materials and methods: Polymicrobial sepsis was induced by cecal ligation and puncture in mice. Vascular reactivity was assessed by organ bath study and aortic mRNA expression of AT1 and P2Y6 was quantified by qRT-PCR.

Results: Both angiotensin-II and UDP produced higher contractions in the absence of endothelium as well as following inhibition of nitric oxide synthase. Angiotensin-II mediated aortic contraction was antagonized by losartan (AT1 antagonist), but not by PD123319 (AT2 antagonist) whereas UDP-induced aortic contraction was significantly inhibited by MRS2578 (P2Y6 antagonist). In addition, MRS2578 significantly inhibited the contractile response of Ang-II. Compared to SO mice, angiotensin-II and UDP-induced maximum contraction were found to be significantly attenuated in sepsis. Accordingly, aortic mRNA expression of AT1a receptors was significantly down-regulated while that of P2Y6 receptors was significantly increased in sepsis. 1400 W (a selective iNOS inhibitor) significantly reversed angiotensin-II-induced vascular hyporeactivity in sepsis without affecting UDP-induced hypo-reactivity.

Conclusion: Sepsis-induced vascular hyporeactivity to angiotensin-II is mediated by enhanced expression of iNOS. Moreover, AT1R-P2Y6 cross talk/heterodimerization could be a novel target for regulating vascular dysfunction in sepsis.

Keywords: AT1 receptor; P2Y6 receptor; Polymicrobial sepsis; iNOS.

MeSH terms

  • Angiotensin II* / pharmacology
  • Animals
  • Mice
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sepsis* / complications
  • Sepsis* / genetics
  • Uridine Diphosphate

Substances

  • N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea
  • Angiotensin II
  • RNA, Messenger
  • Uridine Diphosphate